New Evidence for Stroke Prevention
- 18 September 2002
- journal article
- case report
- Published by American Medical Association (AMA) in JAMA
- Vol. 288 (11), 1396-1398
- https://doi.org/10.1001/jama.288.11.1396
Abstract
Stroke is a leading cause of morbidity and mortality in most developed nations. There is a significant body of evidence supporting strategies that target primary and secondary stroke prevention. This evidence cannot be broadly applied to all patients, and each patient's situation and values must be considered with regard to shared evidence-based decision making. Several models can be used to apply evidence to individual patients, including formal clinical decision analysis, decision aids, or simpler tools such as the likelihood of being helped vs harmed. Various programmatic models of providing patient care in stroke prevention may also be useful; these include specialized clinics or disease-management programs, anticoagulation management services, and self-testing and management of anticoagulation by patients.Keywords
This publication has 7 references indexed in Scilit:
- Randomised trials of secondary prevention programmes in coronary heart disease: systematic reviewBMJ, 2001
- Medicolegal Implications of the Consensus ConferenceChest, 2001
- Community impact of anticoagulation services: rationale and design of the Managing Anticoagulation Services Trial (MAST).Journal of Thrombosis and Thrombolysis, 2000
- Decision aids for patients facing health treatment or screening decisions: systematic reviewBMJ, 1999
- Choosing Antithrombotic Therapy for Elderly Patients With Atrial Fibrillation Who Are at Risk for FallsArchives of Internal Medicine, 1999
- Consensus Guidelines for Coordinated Outpatient Oral Anticoagulation Therapy ManagementAnnals of Pharmacotherapy, 1997
- Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study.Stroke, 1994